Bellevue Life Sciences Acquisition Corp.

BLACNASDAQFinancial Services

$3.01

$-3.72(-55.27%)

Market Cap$6982448

P/E Ratio—

52W High$13.4

52W Low$3.01

Avg Volume15K

Open$3.89

Beta0.53

Overview

Bellevue Life Sciences Acquisition Corp. (BLAC) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BLAC · earnings · updated Jun 8, 2026

Latest Earnings

Q3 FY2023Report Date: Sep 30, 2023

EPS Actual

$0.01

Revenue

—

Fiscal Period

Q3 FY2023

FY ends December

Report Date

Sep 30, 2023

After Market Close

BLAC reports quarterly as a NASDAQ-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.09

Rev. $41.31B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.09

Rev. Est.$41.31B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q3 FY2023	Sep 30, 2023	—	$0.01	—	—	—	—
— Q4 FY2022	Dec 31, 2022	—	-$17694.00	—	—	—	—

Q3 FY2023

Sep 30, 2023

EPS Actual

$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2022

Dec 31, 2022

EPS Actual

-$17694.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for BLAC.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2023	Sep 30, 2023	—	$10.40	$10.40	+0.00%
— Q4 FY2022	Dec 31, 2022	—	No price data	$10.10	—

Q3 FY2023+0.00%

Report Date

Sep 30, 2023

EPS Beat/Miss

—

Price Before

$10.40

Price After

$10.40

Q4 FY2022—

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

—

Price After

$10.10

Beat Rate0 / 2 quarters

Largest Move+0.00% (Q3 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Bellevue Life Sciences Acquisition Corp. (BLAC) most recently reported earnings on September 30, 2023 for Q3 FY2023, posting EPS of $0.01 (in line with the analyst consensus of —). The next BLAC earnings date is expected around September 1, 2026.

Each quarter, investors track BLAC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLAC revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BLAC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BLAC earnings · 4 questions

Bellevue Life Sciences Acquisition Corp.'s next earnings report is expected around September 1, 2026. BLAC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLAC historically reports after market close (AMC).

BLAC earnings datewhen is BLAC earningsBLAC next earnings datewhen does BLAC report earningsBLAC earnings calendar

▸ Source: FMP · Bellevue Life Sciences Acquisition Corp. SEC filings · US GAAP · Bellevue Life Sciences Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026